New Age Alpha Advisors LLC Purchases New Stake in Sabra Healthcare REIT, Inc. $SBRA

New Age Alpha Advisors LLC purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 45,741 shares of the real estate investment trust’s stock, valued at approximately $866,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cornerstone Wealth Management LLC grew its position in shares of Sabra Healthcare REIT by 256.6% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock worth $742,000 after buying an additional 28,625 shares during the period. AlphaQuest LLC grew its position in shares of Sabra Healthcare REIT by 309.2% during the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after buying an additional 109,444 shares during the period. Bank of Montreal Can grew its position in shares of Sabra Healthcare REIT by 8.2% during the 3rd quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after buying an additional 211,686 shares during the period. Allianz Asset Management GmbH grew its position in shares of Sabra Healthcare REIT by 9.9% during the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock worth $16,832,000 after buying an additional 81,293 shares during the period. Finally, Greenland Capital Management LP acquired a new position in shares of Sabra Healthcare REIT during the 3rd quarter worth about $4,194,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 1.7%

NASDAQ:SBRA opened at $20.45 on Thursday. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $21.28. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The stock has a market capitalization of $5.16 billion, a PE ratio of 32.46, a price-to-earnings-growth ratio of 1.56 and a beta of 0.67. The business’s 50-day simple moving average is $20.32 and its 200-day simple moving average is $19.69.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $221.75 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the previous year, the business posted $0.37 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is 190.48%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on SBRA shares. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. Citigroup boosted their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, March 26th. Scotiabank boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. Finally, Cantor Fitzgerald boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.30.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.